March 1, 2011 – Medtronic, St. Jude Medical and Biotronik have emerged as leaders in the €2.8 billion European cardiac rhythm management (CRM) electrophysiology and ablation market, according to iData Research. The companies have been particularly successful in the telehealth monitoring for cardiac implantable electric devices (CIEDs).
March 1, 2011 – A bioprosthetic heart valve has demonstrated positive performance at 12 years, according to a study published in The Journal of Thoracic and Cardiovascular Surgery. The Mosaic heart valve, from Medtronic, was evaluated in patients who had aortic valve replacement (AVR) and mitral valve replacement (MVR).
March 1, 2011 – The U.S. Food and Drug Administration (FDA) approved azilsartan medoxomil to treat high blood pressure (hypertension) in adults. Azilsartan medoxomil, also known as Edarbi, is made by Takeda Pharmaceutical North America.
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
March 1, 2011 – A new study assessing the utility of genetic testing to determine a personalized warfarin dose for individual patients has begun at Overlake Hospital Medical Center in Bellevue, Wash. The WARFARIN Study will help determine if genetic testing can reduce a patient’s risk of serious bleeding or clotting events. It will use a test developed by Iverson Genetic Diagnostics.
February 28, 2011 – Scientists have identified a protein that plays a key role in debilitating changes that occur in the heart after a heart attack, according to research reported in Circulation Research: Journal of the American Heart Association.
February 28, 2011 – At the National Institutes of Health (NIH) summit on managing radiation dose in computerized tomography, representatives from the American College of Radiology (ACR) outlined strategies for transforming computed tomography (CT) technology and minimizing radiation exposure.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
February 25, 2011 – Although it may seem like the flu, dizziness, nausea and achiness can be signs of a heart attack in women. While heart attacks affect both men and women, the symptoms of a heart attack are surprisingly different between the genders.
February 25, 2011 – A new upgrade program will give customers a cost-effective way to access the latest magnetic resonance (MR) technology without having to purchase a new system. The reNew program gives Toshiba Vantage customers multiple upgrade options, including paths to a Vantage Atlas or Vantage Titan.
February 25, 2011 – A diagnostic test used to help treat patients with high cholesterol received CE mark approval in Europe. The KIF6 genotyping assay, from Abbott, detects a genetic marker that may be used in conjunction with clinical evaluation and patient assessment for the identification of individuals at risk for coronary heart disease (CHD).
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
February 25, 2011 – A larger transcatheter aortic heart valve has received the CE mark. The 29 mm version of the Sapien XT valve, from Edwards Lifesciences, promises to expand the number of patients who can be treated.
February 24, 2011 – The U.S. Food and Drug Administration (FDA) will no longer require review or approval of technology that helps increase interoperability between devices and information systems. The move is being made to simplify the flow of information between medical devices and electronic medical record systems.
February 24, 2011 – Upsher-Smith Laboratories, is voluntarily recalling one lot (lot #284081) of Jantoven Warfarin Sodium, USP, 3 mg tablets, an anticoagulant with an expiration date of September 2012, NDC # 0832-1214-00.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
February 24, 2011 – A percutaneous microwave tissue ablation (pMTA) system will be unveiled at the European Congress of Radiology (ECR) in Vienna, Austria, March 4-7. The Accu2i pMTA system, from Microsulis Medical is cleared for use in Europe, the United States and Canada. Alongside the Accu2i, Microsulis will feature case studies from key centers using the system.
February 22, 2011 – More than 29 IHE Integration profiles were successfully certified at the IHE North American Connectathon in Chicago. The announcement from Medweb came at the 2011 Healthcare Information and Management Systems Society (HIMMS).
February 21, 2011 – A cardiac computed tomography (CT) report engine was approved by the U.S. Food and Drug Administration (FDA) to save physicians' time, to present instant feedback on their interpretation and to vastly reduce time to diagnosis. The C saves physicians time, presents instant feedback on their interpretation and vastly reduces time to diagnosis.